AV

Avro Life Science

YC W18

Waterloo, CA · 8 employees · 4 known investors

avrolifesci.com ↗

Avro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.

Founders & leadership· Y Combinator alumni (W18)

Shak LakhaniinFounder

Keean SaraniinFounder

Investors · 4

FI

Fifty YearsSan Francisco

HE

Heuristic Capital PartnersSanta Clara

UP

UpHonest CapitalPalo Alto

Y

Y CombinatorSan Francisco · $500K – $500K